Activation of liver X receptor-α reduces activation of the renal and cardiac renin-angiotensin-aldosterone system

Laboratory Investigation

Volumn 90, Issue 4, 2010, Pages 630-636

  Kuipers, Irma ^a   Van Der Harst, Pim ^a   Kuipers, Folkert ^a   Van Genne, Linda ^a   Goris, Maaike ^a   Lehtonen, Jukka Y ^b   Van Veldhuisen, Dirk J ^a   Van Gilst, Wiek H ^a   De Boer, Rudolf A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Division of Cardiology   (Finland)

Author keywords

Angiotensin; Cholesterol; Hypertension; Kidney; Nuclear receptors; Renin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE; ISOPRENALINE; LIVER X RECEPTOR ALPHA; MESSENGER RNA; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; RENIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART; HUMAN; HUMAN CELL; KIDNEY; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; WILD TYPE;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; ORPHAN NUCLEAR RECEPTORS; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER;

EID: 77950357481     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2010.7     Document Type: Article

References (15)

1. Tontonoz P, Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 2003;17:985-993.
2. Peet DJ, Turley SD, Ma W, et al. Cholesterol and bile acid metabolism are impaired in mice lacking the nuclear oxysterol receptor LXR alpha. Cell 1998;93:693-704.
3. Venkateswaran A, Laffitte BA, Joseph SB, et al. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci USA 2000;97:12097-12102.
4. Willy PJ, Umesono K, Ong ES, et al. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev 1995;9: 1033-1045.
5. Peet DJ, Janowski BA, Mangelsdorf DJ. The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev 1998;8:571-575.
6. Chen M, Beaven S, Tontonoz P. Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha. J Lipid Res 2005;46:2570-2579.
7. Morello F, de Boer RA, Steffensen KR, et al. Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest 2005;115: 1913-1922.
8. Persson PB, Skalweit A, Mrowka R, et al. Control of renin synthesis. Am J Physiol Regul Integr Comp Physiol 2003;285:R491-R497.
9. Leik CE, Carson NL, Hennan JK, et al. GW3965, a synthetic liver X receptor (LXR) agonist, reduces angiotensin II-mediated pressor responses in Sprague-Dawley rats. Br J Pharmacol 2007;151:450-456.
10. van der Veen JN, Havinga R, Bloks VW, et al. Cholesterol feeding strongly reduces hepatic VLDL-triglyceride production in mice lacking the liver X receptor alpha. J Lipid Res 2007;48:337-347.
11. Schultz JR, Tu H, Luk A, et al. Role of LXRs in control of lipogenesis. Genes Dev 2000;14:2831-2838.
12. Tamura K, Chen YE, Horiuchi M, et al. LXRalpha functions as a cAMP-responsive transcriptional regulator of gene expression. Proc Natl Acad Sci USA 2000;97:8513-8518.
13. Kuipers I, van der Harst P, Navis G, et al. Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system. Hypertension 2008;51:1442-1448.
14. Elton TS, Martin MM. Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension 2007;49:953-961.
15. Imayama I, Ichiki T, Patton D, et al. Liver X receptor activator downregulates angiotensin II type 1 receptor expression through dephosphorylation of Sp1. Hypertension 2008;51:1631-1636.